CN102626330A - 一种用可降解生物相容材料制成的十二指肠内覆膜及应用 - Google Patents
一种用可降解生物相容材料制成的十二指肠内覆膜及应用 Download PDFInfo
- Publication number
- CN102626330A CN102626330A CN201210136379XA CN201210136379A CN102626330A CN 102626330 A CN102626330 A CN 102626330A CN 201210136379X A CN201210136379X A CN 201210136379XA CN 201210136379 A CN201210136379 A CN 201210136379A CN 102626330 A CN102626330 A CN 102626330A
- Authority
- CN
- China
- Prior art keywords
- duodenum
- tube
- overlay film
- ampulla
- covering membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000560 biocompatible material Substances 0.000 title claims abstract description 20
- 230000002183 duodenal effect Effects 0.000 title abstract description 29
- 239000012528 membrane Substances 0.000 title abstract 7
- 210000001198 duodenum Anatomy 0.000 claims abstract description 103
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 27
- 208000008589 Obesity Diseases 0.000 claims abstract description 15
- 235000020824 obesity Nutrition 0.000 claims abstract description 15
- 230000006378 damage Effects 0.000 claims abstract description 11
- 210000001630 jejunum Anatomy 0.000 claims abstract description 10
- 230000001739 rebound effect Effects 0.000 claims abstract description 6
- 239000003708 ampul Substances 0.000 claims description 50
- 239000007943 implant Substances 0.000 claims description 16
- 238000001727 in vivo Methods 0.000 claims description 12
- 230000000968 intestinal effect Effects 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 9
- 230000002496 gastric effect Effects 0.000 claims description 9
- 230000004044 response Effects 0.000 claims description 9
- 230000008855 peristalsis Effects 0.000 claims description 8
- 238000004804 winding Methods 0.000 claims description 6
- 230000006735 deficit Effects 0.000 claims description 3
- 210000002784 stomach Anatomy 0.000 abstract description 18
- 210000004913 chyme Anatomy 0.000 abstract description 12
- 230000004888 barrier function Effects 0.000 abstract description 8
- 210000000941 bile Anatomy 0.000 abstract description 8
- 210000001819 pancreatic juice Anatomy 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 208000027418 Wounds and injury Diseases 0.000 abstract description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 4
- 208000014674 injury Diseases 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 210000000416 exudates and transudate Anatomy 0.000 abstract 1
- 230000005176 gastrointestinal motility Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 description 38
- 239000004814 polyurethane Substances 0.000 description 27
- 229920002635 polyurethane Polymers 0.000 description 27
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 18
- 239000008103 glucose Substances 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 16
- 206010030113 Oedema Diseases 0.000 description 15
- 230000037396 body weight Effects 0.000 description 15
- 229910052751 metal Inorganic materials 0.000 description 14
- 239000002184 metal Substances 0.000 description 14
- 230000015556 catabolic process Effects 0.000 description 13
- 238000006731 degradation reaction Methods 0.000 description 13
- 206010015150 Erythema Diseases 0.000 description 12
- 231100000321 erythema Toxicity 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 230000001154 acute effect Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 229920001610 polycaprolactone Polymers 0.000 description 9
- 229920000728 polyester Polymers 0.000 description 9
- 229920001577 copolymer Polymers 0.000 description 8
- 239000013642 negative control Substances 0.000 description 8
- 231100000252 nontoxic Toxicity 0.000 description 8
- 230000003000 nontoxic effect Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 229920000570 polyether Polymers 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- BJZYYSAMLOBSDY-QMMMGPOBSA-N (2s)-2-butoxybutan-1-ol Chemical compound CCCCO[C@@H](CC)CO BJZYYSAMLOBSDY-QMMMGPOBSA-N 0.000 description 6
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000009102 absorption Effects 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000006399 behavior Effects 0.000 description 6
- 210000000078 claw Anatomy 0.000 description 6
- 238000004043 dyeing Methods 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000004632 polycaprolactone Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 239000012781 shape memory material Substances 0.000 description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 4
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 239000004721 Polyphenylene oxide Substances 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000000750 progressive effect Effects 0.000 description 4
- 206010002091 Anaesthesia Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 230000001427 coherent effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229920000768 polyamine Polymers 0.000 description 3
- 239000004626 polylactic acid Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000004017 vitrification Methods 0.000 description 3
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 235000019752 Wheat Middilings Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 2
- 229910002065 alloy metal Inorganic materials 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 230000001447 compensatory effect Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 230000009193 crawling Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- JGFBRKRYDCGYKD-UHFFFAOYSA-N dibutyl(oxo)tin Chemical compound CCCC[Sn](=O)CCCC JGFBRKRYDCGYKD-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013360 fish flour Nutrition 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000012633 leachable Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000020442 loss of weight Diseases 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000007886 mutagenicity Effects 0.000 description 2
- 231100000299 mutagenicity Toxicity 0.000 description 2
- 210000001087 myotubule Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 2
- 229950004354 phosphorylcholine Drugs 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 208000016261 weight loss Diseases 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical class OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 description 1
- 206010050456 Anastomotic leak Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010071759 Muscle oedema Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 208000006193 Pulmonary infarction Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- -1 add fresh culture Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 229920003232 aliphatic polyester Polymers 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000007681 bariatric surgery Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 229940059574 pentaerithrityl Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 229920006146 polyetheresteramide block copolymer Polymers 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000007575 pulmonary infarction Effects 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- QXJQHYBHAIHNGG-UHFFFAOYSA-N trimethylolethane Chemical compound OCC(C)(CO)CO QXJQHYBHAIHNGG-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0076—Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/045—Stomach, intestines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
- A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Nursing (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210136379.XA CN102626330B (zh) | 2012-05-05 | 2012-05-05 | 一种用可降解生物相容材料制成的十二指肠内覆膜及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210136379.XA CN102626330B (zh) | 2012-05-05 | 2012-05-05 | 一种用可降解生物相容材料制成的十二指肠内覆膜及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102626330A true CN102626330A (zh) | 2012-08-08 |
CN102626330B CN102626330B (zh) | 2014-06-25 |
Family
ID=46584847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210136379.XA Expired - Fee Related CN102626330B (zh) | 2012-05-05 | 2012-05-05 | 一种用可降解生物相容材料制成的十二指肠内覆膜及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102626330B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102783976A (zh) * | 2012-08-21 | 2012-11-21 | 万平 | 一种用静电纺制成的十二指肠内覆膜 |
CN102824239A (zh) * | 2012-09-12 | 2012-12-19 | 上海市第六人民医院 | 一种小肠袖套 |
WO2013166926A1 (zh) * | 2012-05-05 | 2013-11-14 | Wan Ping | 一种用可降解生物相容材料制成的十二指肠内覆膜及应用 |
WO2014161446A1 (zh) * | 2013-03-31 | 2014-10-09 | Wan Ping | 一种十二指肠内覆膜 |
GB2513513A (en) * | 2012-05-05 | 2014-10-29 | Ping Wan | Duodenal internal covering membrane made of degradable biocompatible material and application thereof |
CN104174072A (zh) * | 2014-08-07 | 2014-12-03 | 西安科技大学 | 一种医用聚氨酯胰肠吻合器材料及其制备方法 |
CN105078642A (zh) * | 2014-05-14 | 2015-11-25 | 饶永 | 一种子宫内植入物 |
CN105163793A (zh) * | 2013-02-28 | 2015-12-16 | 波士顿科学国际有限公司 | 沿胆道和/或胰管使用的医疗装置 |
CN105596128A (zh) * | 2016-01-23 | 2016-05-25 | 万平 | 十二指肠内覆膜 |
CN109833128A (zh) * | 2019-03-11 | 2019-06-04 | 曲梅花 | 大小鼠十二指肠-空肠内置套管 |
CN110800497A (zh) * | 2019-11-06 | 2020-02-18 | 贵州省烟草公司黔南州公司 | 缠绕式的植物药物注射装置 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005060869A1 (en) * | 2003-12-09 | 2005-07-07 | Gi Dynamics, Inc. | Intestinal sleeve |
US7695446B2 (en) * | 2002-12-02 | 2010-04-13 | Gi Dynamics, Inc. | Methods of treatment using a bariatric sleeve |
CN101843536A (zh) * | 2010-04-09 | 2010-09-29 | 张发明 | 十二指肠套管及其输送器 |
CN102083393A (zh) * | 2008-04-11 | 2011-06-01 | 戈尔企业控股股份有限公司 | 医疗器械及其制造方法 |
KR101064190B1 (ko) * | 2009-07-02 | 2011-09-14 | 주식회사 엠아이텍 | 다이어트용 스텐트 |
CN201987704U (zh) * | 2010-12-06 | 2011-09-28 | 北京畅想天行医疗技术有限公司 | 十二指肠-空肠内置套管 |
CN202665589U (zh) * | 2012-05-05 | 2013-01-16 | 万平 | 一种用可降解生物相容材料制成的十二指肠内覆膜 |
-
2012
- 2012-05-05 CN CN201210136379.XA patent/CN102626330B/zh not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7695446B2 (en) * | 2002-12-02 | 2010-04-13 | Gi Dynamics, Inc. | Methods of treatment using a bariatric sleeve |
WO2005060869A1 (en) * | 2003-12-09 | 2005-07-07 | Gi Dynamics, Inc. | Intestinal sleeve |
CN102083393A (zh) * | 2008-04-11 | 2011-06-01 | 戈尔企业控股股份有限公司 | 医疗器械及其制造方法 |
KR101064190B1 (ko) * | 2009-07-02 | 2011-09-14 | 주식회사 엠아이텍 | 다이어트용 스텐트 |
CN101843536A (zh) * | 2010-04-09 | 2010-09-29 | 张发明 | 十二指肠套管及其输送器 |
CN201987704U (zh) * | 2010-12-06 | 2011-09-28 | 北京畅想天行医疗技术有限公司 | 十二指肠-空肠内置套管 |
CN202665589U (zh) * | 2012-05-05 | 2013-01-16 | 万平 | 一种用可降解生物相容材料制成的十二指肠内覆膜 |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2513513A (en) * | 2012-05-05 | 2014-10-29 | Ping Wan | Duodenal internal covering membrane made of degradable biocompatible material and application thereof |
GB2513513B (en) * | 2012-05-05 | 2019-04-17 | Wan Ping | Duodenum endothelium membrane made from degradable biocompatible materials and application thereof |
WO2013166926A1 (zh) * | 2012-05-05 | 2013-11-14 | Wan Ping | 一种用可降解生物相容材料制成的十二指肠内覆膜及应用 |
GB2518800B (en) * | 2012-08-21 | 2018-12-19 | Wan Ping | An internal covering membrane of duodenum prepared by electrospinning method |
AU2013305317B2 (en) * | 2012-08-21 | 2016-03-17 | Ping Wan | Duodenum endothelium membrane made by electrostatic spinning |
WO2014029302A1 (zh) * | 2012-08-21 | 2014-02-27 | Wan Ping | 一种用静电纺制成的十二指肠内覆膜 |
CN102783976A (zh) * | 2012-08-21 | 2012-11-21 | 万平 | 一种用静电纺制成的十二指肠内覆膜 |
CN102783976B (zh) * | 2012-08-21 | 2014-12-10 | 万平 | 一种用静电纺制成的十二指肠内覆膜 |
GB2518800A (en) * | 2012-08-21 | 2015-04-01 | Ping Wan | Duodenum endothelium membrane made by electrostatic spinning |
US20150230958A1 (en) * | 2012-08-21 | 2015-08-20 | Ping Wan | Internal covering membrane of duodenum prepared by electrospinning method |
CN102824239A (zh) * | 2012-09-12 | 2012-12-19 | 上海市第六人民医院 | 一种小肠袖套 |
CN105163793A (zh) * | 2013-02-28 | 2015-12-16 | 波士顿科学国际有限公司 | 沿胆道和/或胰管使用的医疗装置 |
WO2014161446A1 (zh) * | 2013-03-31 | 2014-10-09 | Wan Ping | 一种十二指肠内覆膜 |
GB2527999A (en) * | 2013-03-31 | 2016-01-06 | Ping Wan | Duodenal internal covering membrane |
US9918862B2 (en) | 2013-03-31 | 2018-03-20 | Ping Wan | Internal covering membrane of duodenum |
GB2527999B (en) * | 2013-03-31 | 2020-04-15 | Wan Ping | Internal covering membrane of duodenum |
AU2014247462B2 (en) * | 2013-03-31 | 2017-03-02 | Ping Wan | Duodenal internal covering membrane |
CN105078642A (zh) * | 2014-05-14 | 2015-11-25 | 饶永 | 一种子宫内植入物 |
CN105078642B (zh) * | 2014-05-14 | 2018-07-24 | 吴江永元生物科技有限公司 | 一种子宫内植入物 |
CN104174072B (zh) * | 2014-08-07 | 2016-03-23 | 西安科技大学 | 一种医用聚氨酯胰肠吻合器材料及其制备方法 |
CN104174072A (zh) * | 2014-08-07 | 2014-12-03 | 西安科技大学 | 一种医用聚氨酯胰肠吻合器材料及其制备方法 |
WO2017124847A1 (zh) * | 2016-01-23 | 2017-07-27 | 万平 | 十二指肠内覆膜 |
GB2562962A (en) * | 2016-01-23 | 2018-11-28 | Wan Ping | Covering film within duodenum |
CN105596128A (zh) * | 2016-01-23 | 2016-05-25 | 万平 | 十二指肠内覆膜 |
US20190029858A1 (en) * | 2016-01-23 | 2019-01-31 | Ping Wan | Duodenal internal covering membrane for duodenum |
CN109833128A (zh) * | 2019-03-11 | 2019-06-04 | 曲梅花 | 大小鼠十二指肠-空肠内置套管 |
CN110800497A (zh) * | 2019-11-06 | 2020-02-18 | 贵州省烟草公司黔南州公司 | 缠绕式的植物药物注射装置 |
CN110800497B (zh) * | 2019-11-06 | 2021-04-20 | 贵州省烟草公司黔南州公司 | 缠绕式的植物药物注射装置 |
Also Published As
Publication number | Publication date |
---|---|
CN102626330B (zh) | 2014-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102626330B (zh) | 一种用可降解生物相容材料制成的十二指肠内覆膜及应用 | |
CN103800097B (zh) | 一种组织修复用纤维膜及其制造方法和应用 | |
CN202665589U (zh) | 一种用可降解生物相容材料制成的十二指肠内覆膜 | |
CN101815545A (zh) | 用于促进中空器官或中空器官一部分体内重建的假体 | |
CN108938163A (zh) | 胃导流器及其释放方法 | |
US20130344114A1 (en) | Composition for repairing cartilage tissue and method for making the same | |
Kanazawa et al. | Current reconstructive techniques following head and neck cancer resection using microvascular surgery | |
EP3646827B1 (en) | Gastric diverter and antibacterial digestive tract catheter thereof | |
Wood et al. | Mechanical lengthening of porcine small intestine with decreased forces | |
CN201316330Y (zh) | 组织工程化组合式人体腔管代用品 | |
Zhao et al. | Progress in absorbable polymeric thread used as acupoint embedding material | |
CN108635092A (zh) | 胃导流器及其消化道支架 | |
GB2513513A (en) | Duodenal internal covering membrane made of degradable biocompatible material and application thereof | |
CN208864588U (zh) | 胃导流器及其消化道支架 | |
US20220347347A1 (en) | Ligament Repair Scaffold | |
CN202313669U (zh) | 可自动塑形钛网 | |
CN103301510B (zh) | 一种针灸埋植材料 | |
US20240024541A1 (en) | Methods and devices for medical implants | |
Polshina et al. | A comprehensive approach to the delayed treatment of post-burn facial scars | |
US20220296648A1 (en) | Composition for regenerating nucleus pulposus | |
CN208229126U (zh) | 一种便于植入固定的纳米药物的存储单元 | |
Aguilar | Biomaterial Science: Anatomy and Physiology Aspects | |
CN105641736A (zh) | 具有杀菌消炎作用的医用缝合线及其制法 | |
AU2022224692A1 (en) | Methods and devices for medical implants | |
Katayama et al. | Use of parallel loop line prosthesis for management of post surgical tracheal collapse in a dog. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120808 Assignee: Zhejiang Zuo yuan Medical Technology Co.,Ltd. Assignor: Wan Ping Contract record no.: 2017330000081 Denomination of invention: Duodenal internal covering membrane made of degradable biocompatible material and application thereof Granted publication date: 20140625 License type: Common License Record date: 20170608 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140625 |
|
CF01 | Termination of patent right due to non-payment of annual fee |